Hereditary Cancer Syndromes

2 researchers across 1 institution

2 Researchers
1 Institutions
0 Grant PIs
0 High Impact

Research in hereditary cancer syndromes investigates the genetic basis of increased cancer risk within families. This area explores the identification of specific gene mutations, their inheritance patterns, and the associated lifetime risk for various cancers. Studies often involve genetic testing, detailed family history analysis, and the development of risk assessment models. Investigations also extend to understanding the biological mechanisms by which these mutations contribute to cancer development and progression, as well as exploring the psychosocial impacts on individuals and families.

Given Arkansas's demographic profile and health landscape, research in hereditary cancer syndromes holds particular relevance. Understanding the prevalence and specific genetic predispositions within state populations can inform targeted screening programs and genetic counseling services. This work is crucial for addressing potential health disparities in cancer diagnosis and outcomes across the state, aiming to improve early detection and preventative strategies for Arkansans.

This field draws upon expertise from genomics, public health, health policy, and genetic counseling. Collaboration with researchers in health disparities and outcomes, electronic health records, and healthcare policy is essential for translating findings into effective clinical practice and public health interventions. Engagement spans multiple institutions, fostering a comprehensive approach to understanding and managing hereditary cancer risks.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Melinda E. Simonson UAMS 3 28
John F. Jenkins UAMS 3 43

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
7,286 works in 2025
+2.3% CAGR 2018–2025
Leadership concentration
5.7% held by global top 5 institutions
Fragmented HHI 24
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2025 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 2,450
  2. 2 Harvard University 2,068
  3. 3 Memorial Sloan Kettering Cancer Center 1,928
  4. 4 Johns Hopkins University 1,580
  5. 5 National Cancer Institute 1,459
Browse All 2 Researchers in Directory